Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailability

References

• RadtkeMPure drug nanoparticles for the formulation of poorly soluble drugsNew Drugs20013 62 68
   Google Scholar
• LipinskiCPoor aqueous solubility-an industry wide problem in drug discoveryAm Pharm Rev200253 82 85
   Google Scholar
• SailorGSethAKParmarGChauhanSJaviaAFormulation and in-vitro evaluation of berberine containing liposome optimized by 32 full factorial designsJ Appl Pharm Sci201557 023 028
   Google Scholar
• DressmannJBReppasCIn vitro, in-vivo correlations for lipophilic, poorly water soluble drugsEur J Pharm Sci200011 73 80
   Web of Science ®Google Scholar
• KesisoglouFPanmaiSWuYNanosizing-oral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev2007597 631 64417601629
   PubMed Web of Science ®Google Scholar
• SalahNHabibSSKhanZHHigh-energy ball milling technique for ZnO nanoparticles as antibacterial materialInt J Nanomedicine20116 863 88621720499
   PubMed Web of Science ®Google Scholar
• PuckettSDTaylorERaimondoTWebsterTJThe relationship between the nanostructure of titanium surfaces and bacterial attachmentBiomaterials2010314 706 71319879645
   PubMed Web of Science ®Google Scholar
• SeoWSLeeJHSunXFeCo/graphitic shell nanocrystals as advanced magnetic-resonance-imaging and near infrared agentsNat Mater2006512 971 97617115025
   PubMed Web of Science ®Google Scholar
• DilnawazFSinghAMohantyCSahooSKDual drug loaded super-paramagnetic iron oxide nanoparticles for targeted cancer therapyBiomaterials20103113 3694 370620144478
   PubMed Web of Science ®Google Scholar
• JacobsCMüllerRHProduction and characterization of a budesonide nanosuspension for pulmonary administrationPharm Res2002192 189 19411883646
   PubMed Web of Science ®Google Scholar
• BilatiUAllémannEDoelkerEDevelopment of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticlesEur J Pharm Sci2005241 67 7515626579
   PubMed Web of Science ®Google Scholar
• KakranMSahooNGTanILLiLPreparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methodsJ Nanopart Res2012143 1 1122448125
   PubMed Web of Science ®Google Scholar
• HussainIKhanFAUllahRKhanNMuhammadZAnalysis of silymarin in the seeds of white and blue capitulum of Silybum marianum plantsAfr J Pharm Pharmacol201156 742 745
   Google Scholar
• DixitNBabootaSKohliKAhmadSAliJSilymarin: a review of pharmacological aspects and bioavailability enhancement approachesInd J Pharmacol2007394 172 179
   Google Scholar
• LoguercioCFestiDSilybin and the liver: from basic research to clinical practiceWorld J Gastroenterol20111718 2288 230121633595
   PubMed Web of Science ®Google Scholar
• LeeDGKimHKParkYGram-positive bacteria specific properties of silybin derived from Silybum marianumArch Pharm Res2003268 597 60012967193
   PubMed Web of Science ®Google Scholar
• AmirsaadatSPilehvar-SoltanahmadiYZarghamiFAlipourSEbrahimnezhadZZarghamiNSilibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cellsArtif Cells Nanomed Biotechnol201712 1 8
   Google Scholar
• ChenCHChangCCShihTHAljuffaliIAYehTSFangJYSelf-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgeryInt J Nanomedicine201510 2403 241625848259
   PubMed Web of Science ®Google Scholar
• LiuCHLinCCHsuWCHighly bioavailable silibinin nanoparticles inhibit HCV infectionGut201610.1136/gutjnl-2016-312019 Epub 2016 Jul 19
   Web of Science ®Google Scholar
• SunHPSuJHMengQSSilibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitroActa Pharmacol Sin2016377 941 94927133295
   PubMed Web of Science ®Google Scholar
• BhushanSPVladimirVCVladimirPTNew developments in liposomal drug deliveryChem Rev201511519 10938 1096626010257
   PubMed Web of Science ®Google Scholar
• BhattacharyaSGhoshAKPhytosomes: the emerging technology for enhancement of bioavailability of botanicals and nutraceuticalsInt J Aesthetic Anti Ageing Med20092 87 91
   Google Scholar
• KurkinVARyzhovVMBiryukovaOVMel’nikovaNBSelekhovVVInteraction of milk-thistle-fruit flavanonols with Langmuir monolayers of lecithin and bilayers of liposomesPharm Chem J2009432 101 109
   Web of Science ®Google Scholar
• GargRGuptaGDGastroretentive floating microspheres of silymarin: preparation and in vitro evaluationTrop J Pharm Res20109 59 66
   Web of Science ®Google Scholar
• El-FarYMZakariaMMGabrMMEl GayarAMEl-SherbinyIMEissaLAA newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetesNanomedicine (Lond)20161119 2581 260227623396
   PubMed Web of Science ®Google Scholar
• KhanSde MatasMZhangJAnwarJNanocrystal preparation: low-energy precipitation method revisitedCryst Growth Des2013137 2766 2777
   Web of Science ®Google Scholar
• WuJWLinLCTsaiTHDrug–drug interactions of silymarin on the perspective of pharmacokineticsJ Ethnopharmacol20091212 185 19319041708
   PubMed Web of Science ®Google Scholar
• WuJWLinLCHungSCChiCWTsaiTHAnalysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability applicationJ Pharm Biomed Anal2007454 635 64117692492
   PubMed Web of Science ®Google Scholar
• ArunprasadKNarayananNRajalakshmiGPreparation and evaluation of solid dispersion of terbinafine hydrochlorideInt J Pharm Sci Rev Res20103 130 134
   Google Scholar
• KhanGMZhuJBIbuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: influence of several parameters and coexcipientsJ Control Release1998561 127 1349801436
   PubMed Web of Science ®Google Scholar
• CostaPLoboJMModeling and comparison of dissolution profilesEur J Pharm Sci2001132 123 13311297896
   PubMed Web of Science ®Google Scholar
• PatelRPPatelMMSolid-state characterization and dissolution properties of lovastatin hydroxypropyl-beta-cyclodextrin inclusion complexPharm Tech2007312 72 81
   Google Scholar
• National Committee for Clinical Laboratory Standards Approved StandardReference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts M 27-A2Wayne PANational Committee for Clinical Laboratory Standards Approved Standard2002
   Google Scholar
• ZhangSLChangJJDamuGLNovel berberine triazoles: synthesis, antimicrobial evaluation and competitive interactions with metal ions to human serum albuminBioorg Med Chem Lett2013234 1008 101223312473
   PubMed Web of Science ®Google Scholar
• DangLYangHBlackSWeiHThe effect of temperature and solvent composition on transformation of β-to α-glycine as monitored in situ by FBRM and PVMOrg Proces Res Dev2009136 1301 1306
   Web of Science ®Google Scholar
• DevarajPKumariPAartiCRenganathanASynthesis and characterization of silver nanoparticles using cannonball leaves and their cytotoxic activity against MCF-7 cell lineJ Nanotechnol2013 1 5
   Google Scholar
• MurdandeSBPikalMJShankarRMBognerRHSolubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysisJ Pharm Sci2010993 1254 126419697391
   PubMed Web of Science ®Google Scholar
• MurdandeSBPikalMJShankarRMBognerRHSolubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticalsPharm Res20102712 2704 271420859662
   PubMed Web of Science ®Google Scholar
• MüllerRHJunghannsJ-UAHDrug nanocrystals/nanosuspensions for the delivery of poorly soluble drugsTorchilinVPNanoparticulates as Drug CarriersLondonImperial College Press2006 236
   Google Scholar
• KakranMSahooNGLiLFabrication of drug nanoparticles by evaporative precipitation of nanosuspensionInt J Pharm20103831–2 285 29219781606
   PubMed Web of Science ®Google Scholar
• ShidRLDholeSNKulkarniNShidSLFormulation and evaluation of nanosuspension delivery system for simvastatinInt J Pharm Sci Nanotechnol20147 2459 2476
   Google Scholar
• JiangTHanNZhaoBXieYWangSEnhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitationDrug Dev Ind Pharm20123810 1230 123922229827
   PubMed Web of Science ®Google Scholar
• MauludinRMüllerRHKeckCMDevelopment of an oral rutin nanocrystal formulationInt J Pharm20093701–2 202 20919114097
   PubMed Web of Science ®Google Scholar
• PardeikeJMüllerRHNanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18Int J Pharm20103911–2 322 32920214969
   PubMed Web of Science ®Google Scholar
• ShahSMHUllahFKhanSSmart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluationDrug Des Devel Ther201610 3837 3850
   PubMed Web of Science ®Google Scholar
• KayaertPVan den MooterGIs the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with naproxen and cinnarizineEur J Pharm Biopharm2012813 650 65622579733
   PubMed Web of Science ®Google Scholar
• Rakelly de OliveiraDRelison TintinoSMorais BragaMFIn vitro antimicrobial and modulatory activity of the natural products silymarin and silibininBiomed Res Int20152015 29279725866771
   PubMed Web of Science ®Google Scholar
• ParkKSKangKCKimJHAdamsDJJohngTNPaikYKDifferential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicansJ Antimicrob Chemother1999435 667 67410382888
   PubMed Web of Science ®Google Scholar
• QuanHCaoYYXuZPotent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazoleAntimicrob Agents Chemother2006503 1096 109916495278
   PubMed Web of Science ®Google Scholar
• OttoMBasis of virulence in community-associated methicillin-resistant Staphylococcus aureusAnnu Rev Microbiol201064 143 16220825344
   PubMed Web of Science ®Google Scholar
• FidelPLVazquezJASobelJDCandida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansClin Microbiol Rev1999121 80 969880475
   PubMed Web of Science ®Google Scholar
• KanafaniZAPerfectJRResistance to antifungal agents: mechanisms and clinical impactClin Infect Dis2008461 120 12818171227
   PubMed Web of Science ®Google Scholar
• GardeteSTomaszAMechanisms of vancomycin resistance in Staphylococcus aureusJ Clin Invest20141247 2836 284024983424
   PubMed Web of Science ®Google Scholar